online medical consultations for glp-1 obesity treatment 3 Takeaways from the Landmark Oral 'Switch' Trial Care Weight Loss Care

Some of the GLP-1 agonists drugs in the pipeline include orforglipron by Eli Lilly and company , survodutide by Boehringer Ingelheim, danuglipron by Pfizer , and retatrutide by Eli Lilly and company , among others

Eligibility criteria vary by study but generally require meeting BMI thresholds and having specific obesity-related conditions

Most cases resolve with time or minor lifestyle tweaks, though chronic or severe headaches may require further evaluation

Shamriz O, NaserEddin A, Mosenzon O, Sviri S, Tal Y

Women generally weigh less than men, which may mean the same dose leads to higher medication levels relative to body size

Initial liraglutide biosimilar comparisons to reference liraglutide revealed similar clinical effectiveness and safety profiles